Genvoya and Social Security Disability Benefits
TELL US WHAT HAPPENED SO WE CAN HELP. FREE CONSULTATION
Contact Us About Your Case
FREE Consultation Today.
Genvoya and Social Security Disability Benefits
Genvoya is a once-daily prescription medication used to treat HIV-1 infection. It combines four medicines in a single tablet:
- elvitegravir
- cobicistat
- emtricitabine
- tenofovir alafenamide, or TAF
Current prescribing information describes Genvoya as a four-drug fixed-dose regimen taken once daily with food in eligible adults and children weighing at least 25 kilograms.
Taking Genvoya does not automatically qualify someone for Social Security Disability benefits.
Many people taking Genvoya achieve excellent viral suppression and continue working. Others may still experience significant limitations from:
- severe fatigue
- peripheral neuropathy
- cognitive problems
- recurrent infections
- nausea or diarrhea
- headaches
- kidney disease
- liver problems
- medication interactions
- other HIV-related complications
For Social Security, the important question is whether HIV, related medical conditions, and treatment effects prevent sustained full-time work.
What Is Genvoya?
Genvoya contains:
- elvitegravir 150 mg, an integrase strand transfer inhibitor
- cobicistat 150 mg, a pharmacokinetic enhancer or “booster”
- emtricitabine 200 mg, a nucleoside reverse transcriptase inhibitor
- tenofovir alafenamide 10 mg, another antiretroviral medication
Cobicistat increases the concentration of elvitegravir by slowing its metabolism. That allows elvitegravir to remain effective at the required level, but it also creates an important potential for drug interactions.
Genvoya must be taken with food.
Can Taking Genvoya Qualify You for Social Security Disability?
Not by itself.
A Genvoya prescription documents treatment for HIV, but Social Security evaluates the underlying disease and its actual functional effects.
A stronger disability claim may exist when HIV or related conditions continue to cause:
- severe fatigue
- recurrent infections
- chronic gastrointestinal problems
- neuropathy
- cognitive impairment
- headaches
- kidney dysfunction
- liver disease
- frequent medical treatment
- excessive absences
- inability to complete full workdays
The strongest claims connect medical findings to specific workplace limitations.
Genvoya and HIV Disability Claims
Adult HIV infection is evaluated under Social Security Blue Book Listing 14.11.
Depending on the evidence, a person may qualify based on:
- certain serious HIV-related diseases
- very low CD4 counts
- qualifying low CD4 measurements combined with severe anemia or weight loss
- repeated HIV-related hospitalizations
- repeated manifestations of HIV causing marked functional limitations
A person who does not meet Listing 14.11 may still qualify if their Residual Functional Capacity, or RFC, prevents past work and other competitive employment.
Genvoya and Viral Suppression
Modern antiretroviral therapy is highly effective at suppressing HIV. Current NIH guidelines emphasize maximal and durable viral suppression as a central goal of treatment because it reduces HIV-related illness and mortality and helps preserve immune function.
But an undetectable viral load does not automatically mean someone can work full time.
A person may continue to experience:
- neuropathy
- chronic fatigue
- cognitive impairment
- chronic pain
- residual effects of prior infections
- kidney disease
- liver disease
- depression
- other medical conditions
Social Security should evaluate actual functional capacity rather than relying on viral-load results alone.
Genvoya and Fatigue
Fatigue was reported in about 5% of treatment-naïve adults receiving Genvoya in the clinical trials summarized in the current prescribing information.
Fatigue may also result from:
- HIV itself
- anemia
- chronic infection
- poor sleep
- depression
- chronic pain
- kidney disease
- other medical conditions
Work-related limitations may include:
- reduced stamina
- slower pace
- poor concentration
- need for additional breaks
- difficulty working consecutive days
- inability to complete full shifts
Genvoya and Nausea
Nausea is the most common adverse reaction reported with Genvoya.
In clinical trials of treatment-naïve adults, nausea occurred in approximately 11% of people receiving Genvoya.
Persistent nausea may interfere with work through:
- poor appetite
- difficulty concentrating
- weakness
- unscheduled breaks
- reduced productivity
- missed work
Nausea alone will rarely establish disability, but it may add to the overall functional burden when combined with severe fatigue, diarrhea, weight loss, or other medical problems.
Genvoya and Diarrhea
Diarrhea was reported in approximately 7% of treatment-naïve adults receiving Genvoya in the clinical trials summarized in the label.
Persistent diarrhea can interfere with employment through:
- frequent restroom trips
- urgent unscheduled breaks
- difficulty remaining at a workstation
- dehydration
- fatigue
- reduced productivity
For a disability claim, the important questions are:
- How often does it occur?
- How urgent is it?
- How long do episodes last?
- Does it require unscheduled restroom breaks?
- Is it documented in medical records?
Genvoya and Headaches
Headache occurred in approximately 6% of treatment-naïve adults receiving Genvoya in the clinical trials reported in the prescribing information.
Frequent or severe headaches may interfere with:
- concentration
- computer work
- reading
- pace
- attendance
- completion of tasks
The disability significance depends on frequency, severity, duration, and treatment response.
Genvoya and Kidney Problems
Kidney function is one of the more important medical issues associated with Genvoya.
Current prescribing information reports postmarketing cases involving TAF-containing products of:
- acute renal failure
- proximal renal tubulopathy
- Fanconi syndrome
The label recommends monitoring serum creatinine, estimated creatinine clearance, urine glucose, and urine protein. Serum phosphorus should also be monitored in patients with chronic kidney disease.
Genvoya is not recommended in some patients with severe renal impairment.
Kidney problems may contribute to:
- fatigue
- weakness
- swelling
- reduced stamina
- difficulty concentrating
- additional medical treatment
- work absences
These limitations may strengthen a disability claim when they are medically documented and functionally significant.
Cobicistat and Changes in Creatinine
Cobicistat can increase serum creatinine by reducing tubular secretion of creatinine without necessarily reducing actual glomerular filtration.
The current label states that this increase generally appears within about two weeks after treatment begins and is reversible after discontinuation.
That distinction matters because an increased creatinine level does not always mean Genvoya has caused true kidney damage.
For disability purposes, the relevant issue is whether the person has actual renal impairment and resulting work limitations.
Genvoya and Drug Interactions
Drug interactions are a particularly important consideration with Genvoya because cobicistat strongly affects CYP3A metabolism.
Current prescribing information lists a number of prescription medications that should not be taken with Genvoya because combinations may either:
- increase other medications to dangerous levels, or
- reduce Genvoya levels enough to cause treatment failure or drug resistance.
Examples of contraindicated medications include certain:
- anticonvulsants
- antimycobacterial drugs
- antipsychotics
- cholesterol medications
- sedative medications
Current NIH guidelines note that elvitegravir must be used with cobicistat and that the combination has a relatively high potential for drug-drug interactions. Because of this and other disadvantages, elvitegravir/cobicistat regimens are no longer recommended by the NIH panel as initial therapy for most people starting HIV treatment.
That does not mean everyone already taking Genvoya should stop it. HIV treatment decisions should be individualized by the treating clinician.
Is Genvoya Still Used for HIV?
Yes.
Genvoya remains an FDA-approved HIV treatment regimen.
However, treatment recommendations have evolved. The October 2026 NIH guidelines favor newer second-generation integrase inhibitor regimens such as bictegravir- and dolutegravir-based therapy for most people beginning treatment. Elvitegravir/cobicistat regimens are no longer preferred for initial treatment because of factors including drug interactions and a lower resistance barrier compared with newer options.
For a disability claim, however, the important issue is not whether Genvoya is the newest regimen.
The issue is whether the person remains functionally limited despite appropriate HIV treatment.
Genvoya and Hepatitis B
Genvoya carries a boxed warning regarding serious exacerbation of hepatitis B after treatment is discontinued in people who are coinfected with HIV and HBV.
Current labeling recommends testing for hepatitis B before or when starting Genvoya and monitoring people with HIV/HBV coinfection if the medication is discontinued.
Hepatitis B complications may cause:
- fatigue
- weakness
- nausea
- liver dysfunction
- reduced stamina
- hospitalization
- additional medical monitoring
Genvoya and Liver Problems
Current labeling also warns about lactic acidosis and severe hepatomegaly with steatosis, including rare fatal cases associated with medications in the same drug classes as components of Genvoya.
Liver complications may interfere with work through:
- severe fatigue
- weakness
- nausea
- reduced endurance
- medical appointments
- hospitalization
A theoretical risk alone does not establish disability. Actual liver impairment and functional consequences should be medically documented.
Genvoya and Mental Health Symptoms
Clinical-trial data involving virologically suppressed adults reported serious suicidal ideation, suicidal behavior, or suicide attempts in fewer than 1% of patients switching to Genvoya; those events occurred in patients with preexisting depression or psychiatric illness.
This does not establish that Genvoya generally causes severe psychiatric illness.
But when a person with HIV also has documented:
- depression
- anxiety
- cognitive impairment
- social withdrawal
- difficulty handling stress
Social Security should evaluate the combined effects of those impairments.
Genvoya and Peripheral Neuropathy
Peripheral neuropathy may persist in people living with HIV even when antiviral treatment is successful.
Symptoms may include:
- burning pain
- numbness
- tingling
- weakness
- poor balance
- difficulty walking
- hand dysfunction
Neuropathy affecting the feet may limit:
- standing
- walking
- climbing
- balance
Neuropathy affecting the hands may interfere with:
- typing
- writing
- gripping
- handling
- fingering
Genvoya and Cognitive Problems
Some people living with HIV experience persistent neurocognitive symptoms even when treatment successfully suppresses the virus.
Possible limitations include:
- poor concentration
- memory problems
- slowed thinking
- difficulty organizing tasks
- reduced mental stamina
- difficulty learning new information
At work, these problems may lead to:
- mistakes
- forgotten instructions
- missed deadlines
- reduced pace
- excessive off-task time
- difficulty multitasking
Can You Work While Taking Genvoya?
Yes.
Many people taking Genvoya work without significant restrictions.
The medication itself is not evidence that a person cannot work.
The more important questions are:
- Is HIV well controlled?
- What complications remain?
- Is fatigue severe?
- Are gastrointestinal symptoms persistent?
- Is neuropathy present?
- Are cognitive problems documented?
- Is kidney or liver disease present?
- Can the person maintain reliable attendance?
- Can the person complete a normal workday and workweek?
Two people taking the same medication may have very different levels of functioning.
Can Genvoya-Related Conditions Prevent Sedentary Work?
Yes.
Sedentary work still requires:
- regular attendance
- sustained concentration
- consistent pace
- hand use
- limited unscheduled breaks
- some standing and walking
- completion of full workdays
Sedentary work may become unrealistic when:
- fatigue limits stamina
- diarrhea requires frequent restroom breaks
- nausea interferes with concentration
- neuropathy affects hand use or mobility
- cognitive impairment causes excessive off-task time
- kidney disease reduces endurance
- recurrent illness causes excessive absences
Simply being able to sit at a desk does not establish the ability to sustain full-time employment.
Genvoya and Residual Functional Capacity
Residual Functional Capacity, or RFC, describes the most a person can still do despite medical limitations.
An HIV disability claim involving Genvoya may include restrictions related to:
- standing
- walking
- lifting
- carrying
- handling
- fingering
- restroom access
- concentration
- pace
- additional breaks
- off-task time
- attendance
For example:
- Fatigue may reduce stamina and pace.
- Diarrhea may require unscheduled breaks.
- Neuropathy may limit walking or hand use.
- Cognitive problems may restrict complex tasks.
- Headaches may produce off-task time.
- Kidney disease may reduce endurance.
- Recurrent illness may cause absences.
The RFC should reflect the combined effects of HIV, related medical conditions, and treatment.
Medical Evidence That May Support a Genvoya Disability Claim
Helpful medical evidence may include:
- infectious disease specialist records
- primary care records
- CD4 counts
- viral-load testing
- kidney-function testing
- urinalysis
- serum phosphorus testing when appropriate
- liver testing
- hepatitis B testing
- hospitalization records
- infection records
- neuropathy evaluations
- cognitive testing
- psychiatric records
- medication history
- documented side effects
- records of missed work
- provider statements describing work limitations
The strongest evidence connects the medical findings to specific workplace problems.
Documenting Genvoya Side Effects
Treatment effects are more persuasive when they are consistently documented in medical records.
Helpful evidence may include:
- nausea
- diarrhea
- headaches
- fatigue
- kidney abnormalities
- medication changes
- treatment interruptions
- clinically significant drug interactions
A strong claim explains not only that a symptom occurs, but:
- how often it happens
- how severe it is
- how long it lasts
- how it affects the ability to work
Doctor Statements About Work Limitations
A treating provider may be able to address:
- fatigue
- walking tolerance
- neuropathy
- hand use
- restroom needs
- cognitive impairment
- concentration
- headaches
- medication effects
- need for breaks
- expected absences
- ability to maintain pace
- ability to complete a full workday
Specific functional opinions are generally more useful than a broad statement that someone is simply “disabled.”
Signs Genvoya May Be Relevant to Your Disability Claim
A claim may be stronger when HIV or related medical problems continue to cause:
- severe fatigue
- recurrent infections
- persistent nausea or diarrhea
- neuropathy
- cognitive impairment
- significant headaches
- kidney dysfunction
- liver problems
- substantial treatment complications
- excessive absences
- inability to complete full shifts
The important issue is whether these limitations remain significant despite treatment.
Common Mistakes in Genvoya Disability Claims
Common problems include:
- relying on the prescription itself as proof of disability
- assuming HIV automatically establishes disability
- assuming an undetectable viral load automatically proves ability to work
- failing to document fatigue
- failing to document restroom needs
- overlooking neuropathy
- ignoring cognitive impairment
- failing to document kidney problems
- overlooking drug interactions
- failing to explain absences
- failing to connect symptoms to specific RFC limitations
A strong claim focuses on what the person can and cannot reliably do despite successful antiviral treatment.
When to Speak With a Social Security Disability Lawyer
Many people seek legal help when:
- their disability claim has been denied
- HIV complications continue despite Genvoya
- fatigue prevents full-time work
- neuropathy limits mobility or hand use
- nausea or diarrhea causes workplace problems
- cognitive symptoms interfere with employment
- kidney or liver disease creates additional limitations
- recurrent illness causes excessive absences
- Social Security assumes viral suppression means the person can work
Our social security disability attorneys can help evaluate how HIV, Genvoya treatment, related medical conditions, treatment effects, and RFC limitations fit into the overall disability claim.
FAQs: Genvoya and Social Security Disability Benefits
Can taking Genvoya qualify me for Social Security Disability?
Not by itself. Social Security evaluates HIV, related medical complications, treatment effects, and the ability to sustain full-time work.
What is Genvoya used to treat?
Genvoya is a complete four-drug regimen used to treat HIV-1 in eligible adults and children. It contains elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.
Is Genvoya taken once a day?
Yes. Current prescribing information recommends one tablet once daily with food for eligible patients.
What are the most common Genvoya side effects?
The most common adverse reaction is nausea. Clinical trials also reported diarrhea, headache, and fatigue.
Can Genvoya cause kidney problems?
Yes. Postmarketing renal problems, including acute renal failure, proximal renal tubulopathy, and Fanconi syndrome, have been reported with TAF-containing products. Kidney monitoring is recommended.
Why does Genvoya have so many drug interactions?
Genvoya contains cobicistat, which inhibits CYP3A metabolism in order to boost elvitegravir levels. That same effect can significantly alter the levels of other medications.
Is Genvoya still recommended as a first-line HIV treatment?
Genvoya remains an FDA-approved HIV regimen, but current NIH guidelines no longer recommend elvitegravir/cobicistat regimens as initial therapy for most people starting HIV treatment because of disadvantages that include drug interactions and a lower resistance barrier than newer integrase-based options.
Why is hepatitis B important when taking Genvoya?
Genvoya carries a boxed warning because severe hepatitis B exacerbations may occur after stopping treatment in people with HIV/HBV coinfection. Hepatitis B testing is recommended before or when beginning treatment.
Can HIV prevent sedentary work?
Potentially. Viral suppression is medically important, but it does not automatically establish work capacity. Persistent fatigue, neuropathy, cognitive impairment, kidney or liver disease, gastrointestinal symptoms, recurrent infections, or other limitations may still prevent sustained employment.
What evidence helps prove a Genvoya-related disability claim?
Helpful evidence may include infectious disease records, CD4 and viral-load testing, kidney and liver testing, hepatitis testing, neuropathy records, cognitive or psychiatric evaluations, medication history, documented treatment effects, and provider statements describing specific work limitations.
What should I do if HIV prevents me from working despite Genvoya?
You may want to speak with a Social Security Disability attorney to evaluate whether your HIV meets Listing 14.11 or whether your combined symptoms, complications, treatment effects, and RFC limitations prevent sustained employment.
Contact MLF Legal for a Free Disability Case Evaluation
If HIV, severe fatigue, neuropathy, cognitive impairment, kidney disease, recurrent infections, Genvoya side effects, or another medical condition prevents you from working, you may qualify for Social Security Disability benefits.
MLF Legal represents disability applicants nationwide. Based in Dallas, Texas, we help individuals across the country pursue disability benefits.
Our social security lawyers can review your situation for free and explain your options.
📞 Call MLF Legal at 214-357-1782 to request a free consultation.
Next Steps:
1st Sign up For a Free One-on-One Disability Case Evaluation
Contact us today to schedule your personalized one-on-one free phone consultation with one of our dedicated legal professionals. Our experienced social security lawyers are here to provide the expert legal guidance and support you need throughout the entire process of your case.
We understand the complexities involved in social security disability claims and are committed to helping you achieve the best possible outcome. Don’t hesitate to reach out and take the first step toward securing the justice you deserve.
2nd Download Free E-Books
Social Security Disability
Navigating the Social Security Disability Benefits process can be complex, but understanding the key steps can help. From gathering medical records to completing the application, this process ensures eligible individuals receive the support they need. Seeking guidance from experts can simplify the journey and increase the chances of a successful outcome.
Call MLF Legal today
214-357-1782
Fill out our online form
for a free consultation.
We only get paid if we win your case.